Rising BioSciences, Inc. RBII
Finances
| 2020 | 2019 | |
|---|---|---|
| Revenue | 782.280 K 377.77 % | 163.734 K |
| Net income | 49.762 K 119.65 % | -253.233 K |
| Income before tax | 49.762 K 119.65 % | -253.233 K |
| Income before tax ratio | 0.06 104.11 % | -1.55 |
| EBITDA | 152.687 K 204.77 % | -145.741 K |
| Net income ratio | 0.06 104.11 % | -1.55 |
| Ratio EBITDA | 0.20 121.93 % | -0.89 |
| Gross profit ratio | 0.57 236.13 % | -0.42 |
| Weighted average shs out dil | 1.060 B 25.60 % | 843.725 M |
| Weighted average shs out | 1.060 B 25.60 % | 843.725 M |
| EPS diluted | 0.00 100.00 % | 0.00 |
| Earnings per share | 0.00 100.00 % | 0.00 |
| Gross profit | 448.377 K 750.42 % | -68.937 K |
| Income tax expense | 3.000 -98.01 % | 151.000 |
| Cost of revenue | 333.903 K 43.51 % | 232.671 K |
| General and administrative expenses | 0.000 | 0.000 |
| Selling and marketing expenses | 0.000 | 0.000 |
| Other expenses | 0.000 | 0.000 |
| Operating expenses | 164.210 K 48.84 % | 110.324 K |
| Cost and expenses | 498.113 K 45.22 % | 342.995 K |
| Research and development expenses | 0.000 | 0.000 |
| Selling general and administrative expenses | 164.210 K 48.84 % | 110.324 K |
| Interest income | 0.000 | 0.000 |
| Interest expense | 69.405 K -5.98 % | 73.822 K |
| Depreciation and amortization | 33.520 K 0.00 % | 33.520 K |
| Operating income | 284.170 K 258.52 % | -179.260 K |
| Operating income ratio | 0.36 133.18 % | -1.09 |
| Total other income expenses net | -234.408 K -216.89 % | -73.972 K |
| 2020 | 2019 |
| 2020 | 2019 | |
|---|---|---|
| Net debt | 1.008 M 6.64 % | 945.504 K |
| Total investments | 157.600 K 133.14 % | 67.600 K |
| Total debt | 1.056 M 11.62 % | 946.267 K |
| Accumulated other comprehensive income loss | 426.851 K 4.37 % | 408.978 K |
| Retained earnings | -1.525 M 3.16 % | -1.575 M |
| Common stock | 1.060 M 25.60 % | 843.725 K |
| Total equity | -1.090 M 5.84 % | -1.157 M |
| Other non current liabilities | 0.000 | 0.000 |
| Long term debt | 0.000 | 0.000 |
| Total non current liabilities | 0.000 | 0.000 |
| Other current liabilities | 625.161 K 11.17 % | 562.371 K |
| Deferred revenue | 0.000 | 0.000 |
| Short term debt | 1.056 M 11.62 % | 946.267 K |
| Total current liabilities | 1.730 M 11.09 % | 1.557 M |
| Total liabilities | 1.730 M 11.09 % | 1.557 M |
| Other non current assets | 0.000 -100.00 % | 29.999 K |
| Long term investments | 157.600 K 133.14 % | 67.600 K |
| Intangible assets | 0.000 | 0.000 |
| GoodWill | 0.000 | 0.000 |
| Goodwill and intangible assets | 0.000 | 0.000 |
| Property plant equipment net | 274.243 K -9.10 % | 301.707 K |
| Total non current assets | 431.843 K 8.15 % | 399.306 K |
| Other current assets | 0.000 | 0.000 |
| Short term investments | 0.000 | 0.000 |
| cash and cash equivalents | 47.996 K 6 190.43 % | 763.000 |
| Cash and short term investments | 47.996 K 6 190.43 % | 763.000 |
| Total current assets | 208.575 K 27 236.17 % | 763.000 |
| Inventory | 39.528 K | 0.000 |
| Net receivables | 121.051 K | 0.000 |
| Tax assets | 0.000 | 0.000 |
| Other assets | 0.000 | 0.000 |
| Account payables | 48.620 K -0.16 % | 48.696 K |
| Tax payables | 0.000 | 0.000 |
| Deferred revenue non current | 0.000 | 0.000 |
| Minority interest | 0.000 | 0.000 |
| Capital lease obligations | 0.000 | 0.000 |
| Preferred stock | 8.418 K 0.00 % | 8.418 K |
| Other total stockholders equity | -1.060 M -25.60 % | -843.724 K |
| Deferred tax liabilities non current | 0.000 | 0.000 |
| Other liabilities | 0.000 | 0.000 |
| Total assets | 640.418 K 60.08 % | 400.070 K |
| 2020 | 2019 |
| 2020 | 2019 | |
|---|---|---|
| Deferred income tax | 0.000 | 0.000 |
| Stock based compensation | 0.000 | 0.000 |
| Change in working capital | -93.625 K -158.41 % | 160.281 K |
| Accounts receivables | -121.051 K -240.36 % | 86.243 K |
| Inventory | -39.528 K | 0.000 |
| Accounts payables | -76.000 -135.35 % | 215.000 |
| Other working capital | 67.030 K -9.20 % | 73.823 K |
| Other non cash items | -60.000 K | 0.000 |
| Net cash provided by operating activities | -70.343 K -18.36 % | -59.432 K |
| Investments in property plant and equipment | 0.000 100.00 % | -81.311 K |
| Acquisitions net | -6.056 K 82.75 % | -35.100 K |
| Purchases of investments | 0.000 | 0.000 |
| Sales maturities of investments | 0.000 | 0.000 |
| Other investing activites | 0.000 | 0.000 |
| Net cash used for investing activites | -6.056 K 94.80 % | -116.411 K |
| Debt repayment | 110.000 K | 0.000 |
| Common stock issued | 17.872 K | 0.000 |
| Common stock repurchased | 0.000 | 0.000 |
| Dividends paid | 0.000 | 0.000 |
| Other financing activites | -4.240 K -102.40 % | 176.451 K |
| Net cash used provided by financing activities | 123.632 K -29.93 % | 176.451 K |
| Effect of forex changes on cash | 0.000 | 0.000 |
| Net change in cash | 47.233 K 7 668.59 % | 608.000 |
| Cash at beginning of period | 763.000 392.26 % | 155.000 |
| Cash at end of period | 47.996 K 6 190.43 % | 763.000 |
| Operating cash flow | -70.343 K -18.36 % | -59.432 K |
| Capital expenditure | 3.000 100.00 % | -81.311 K |
| Free CashFlow | -70.343 K 50.02 % | -140.743 K |
| 2020 | 2019 |
| Revenue |
| Net income |
| Income before tax |
| Income before tax ratio |
| EBITDA |
| Net income ratio |
| Ratio EBITDA |
| Gross profit ratio |
| Weighted average shs out dil |
| Weighted average shs out |
| EPS diluted |
| Earnings per share |
| Gross profit |
| Income tax expense |
| Cost of revenue |
| General and administrative expenses |
| Selling and marketing expenses |
| Other expenses |
| Operating expenses |
| Cost and expenses |
| Research and development expenses |
| Selling general and administrative expenses |
| Interest income |
| Interest expense |
| Depreciation and amortization |
| Operating income |
| Operating income ratio |
| Total other income expenses net |
| Net debt |
| Total investments |
| Total debt |
| Accumulated other comprehensive income loss |
| Retained earnings |
| Common stock |
| Total equity |
| Other non current liabilities |
| Long term debt |
| Total non current liabilities |
| Other current liabilities |
| Deferred revenue |
| Short term debt |
| Total current liabilities |
| Total liabilities |
| Other non current assets |
| Long term investments |
| Intangible assets |
| GoodWill |
| Goodwill and intangible assets |
| Property plant equipment net |
| Total non current assets |
| Other current assets |
| Short term investments |
| cash and cash equivalents |
| Cash and short term investments |
| Total current assets |
| Inventory |
| Net receivables |
| Tax assets |
| Other assets |
| Account payables |
| Tax payables |
| Deferred revenue non current |
| Minority interest |
| Capital lease obligations |
| Preferred stock |
| Other total stockholders equity |
| Deferred tax liabilities non current |
| Other liabilities |
| Total assets |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |